Journals / Van Tıp Dergisi / 2017 / Cilt: 24 - Sayı: 4

Prevalence of the Thrombophilic Mutations in Patients with Varicose Veins

Variköz Venleri Olan Hastalarda Trombofilik Mutasyonların Sıklığı

Pages
254–259
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The heterozygous and homozygous MTHFR C677T genotypes were detected in 19 (36.3%) and 9 (16.3%) patients, respectively, giving an overall prevalence of 52.6%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Varicose venous disease is an important disease causing psychiatric, cosmetic, medical and socioeconomic problems.
📊
Key Findings & Data:Factor V Leiden (FVL), Prothrombin gene mutation (PT G20210A) and methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C mutations are the main thrombophilic risk factors used to investigate the causes of venous thrombosis.
💡
Conclusion & Impact:The heterozygous and homozygous MTHFR C677T genotypes were detected in 19 (36.3%) and 9 (16.3%) patients, respectively, giving an overall prevalence of 52.6%.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Varicose venous disease is an important disease causing psychiatric, cosmetic, medical and socioeconomic problems. Factor V Leiden (FVL), Prothrombin gene mutation (PT G20210A) and methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C mutations are the main thrombophilic risk factors used to investigate the causes of venous thrombosis. However, there are few studies on the relationship between varicose venous disease and these thrombophilic risk factors. The aim of our study is to investigate the distribution frequencies of these mutations in patients with varicose veins. Material and Methods: This study included 55 patients with varicose veins. The mutations including FVL, PT G20210A and MTHFR (C677T, A1298C) were investigated in all patients. Polymerase chain reaction (PCR) and the amplification refractory mutation system were used to identify the polymorphisms in the blood of the patients. Results: There were 17 men and 38 women with an average age of 51.08 ± 13.35 years. The heterozygous PT G20210 polymorphism was observed in 3(5.4%) patients. The FVL polymorphism was found in 6 (10.9%) patients. The heterozygous and homozygous MTHFR C677T genotypes were detected in 19 (36.3%) and 9 (16.3%) patients, respectively, giving an overall prevalence of 52.6%. The heterozygous and homozygous MTHFR A1298C genotypes were identified in 29 (54.5%) and 6 (10.9%) patients, respectively, revealing an overall prevalence of 65.4%. Conclusion: This study showed that the prevalence of MTHFR C677T and MTHFR A1298C mutations is quite high in patients with varicose veins, suggesting a contributory role of these mutations in the development of varicose veins. However, our findings should be supported by further studies.

Özet

Amaç: Variköz venöz hastalık psişik, kozmetik, tıbbi ve sosyoekonomik sorunlara yol açan yaygın ve önemli bir hastalıktır. Faktör V Leiden (FVL), protrombin gen mutasyonu (PT G20210A), metilentetrahidrofolat redüktaz (MTHFR) C677T ve MTHFR A1298 mutasyonları venöz tromboz nedenlerini araştırmada kullanılan başlıca trombofilik risk faktörleridir. Bununla birlikte bu mutasyonların variköz venöz hastalıkla ilişkisiyle iligili çalışmalar azdır. Çalışmamızın amacı variköz venleri olan hastalarda bu mutasyonların dağılımının sıklığını araştırmaktır.

🔖

Cite This Article

EKİM, M., EKİM, H. (2017). Prevalence of the Thrombophilic Mutations in Patients with Varicose Veins. Van Tıp Dergisi, Cilt: 24 - Sayı: 4, 254–259. https://ajindex.com/articles/333993

References (14)

  1. Kapısız NS, Kulaoğlu TU, Fen T, Kapısız HF. Potential risk factors for varicose veins with superficial venous reflux. Int J Vasc Med. 2014; 2014: 531689
  2. Pascarella L, Schönbein GWS. Telenjektaziler, retikülee ve variköz venlerin oluşumundaki nedenler. Seminars in Vascular Surgery Turkish Edition 2005; 1(1): 2-5
  3. Akbulut B, Tok M, Uçar Hİ, Durukan B, Böke E. Sık görülen venöz sistem hastalıkları: Görülme sıklığı, risk faktörleri ve tedavi. Anatol J Clin Investig 2009; 3(1): 113-119
  4. Demirkıran MA, Köksoy C, Heper AO, Bengisun U. Variköz ven duvarı hücre dışı matriksi klinik evrelere göre değişiyor mu? Ulusal Cer Derg 2014; 30(4): 186-191
  5. Karathanos C, Exarchou M, Tsezou A, Kyriakou D, Wittens C, Giannoukas A. Factors associated with the development of superficial vein thrombosis in patients with varicose veins. Thromb Res 2013; 132(1): 47-50
  6. Pfisterer L, König G, Hecker M, Korff T. Pathogenesis of varicose veins-lessons from biomechanics. Vasa 2014; 43(2): 88-99
  7. Özsin KK, Rahman A, Özercan İH, Burma O, Uysal A. Alt ekstremite primer varisler,nde apopitozisin rolü. Turkiye Klinikleri J Cardiovasc Sci 2008; 20(3): 184-191
  8. Üstünsoy H, Çine N. Venöz ülser kliniği. TKlinik J Cardiovasc Surg Special Topics 2008; 1(3): 11-16
  9. Gaber Y, Siemens H-J and Schmeller W. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers. Br J Dermatol. 2001; 144(3): 546-548
  10. Milio G, Siragusa S, Mina C, Amato C, Corrado E, Grimaudo S, et al. Superficial venous thrombosis: prevalence of common genetic risk factors and their role on spreading to deep veins. Thromb Res 2008; 123(2): 194-199
  11. Karathanos Ch, Sfyroeras G, Drakou A, Roussas N, Exarchou M, Kyriakou D, et al. Superficial vein thrombosis in patients with varicose veins: Role of thrombophilia factors, age and body mass. Eur J Vasc Endovasc Surg 2012; 43(3): 355-358
  12. Décousus H, Bertoletti L, Frappé P, Becker F, Jaouhari AE, Mismetti P, et al. Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis. Thromb Res 2011; 127 Suppl 3: S81-S85
  13. Enzler MA, Russell D, Schimmelpfennig J. Thermal ablation in the management of superficial thrombophlebitis. Eur J Vasc Endovasc Surg 2012; 43(6): 726-728
  14. Belcaro G, Nicolaides AN, Errichi BM, Cesarone MR, De Sanctis MT, Incandela L, et al. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology 199